Table 5 Comparison of clinical, radiological, and pathological features among CPFE groups with or without thick-walled cystic lesions
| Â | CPFE | Â | |
|---|---|---|---|
| Â | With TWCLs | Without TWCLs | |
|  | (n = 15) | (n = 7) | p-value |
Age, years | Â | Â | Â |
Median | 73 | 68 | 0.7852 |
Range | 60–86 | 64–95 |  |
Smoking history, pack years | Â | Â | Â |
Median | 60 | 80 | 0.2954 |
Range | 20–150 | 30–200 |  |
Extent of emphysema | Â | Â | Â |
0-25% | 1 (6.7%) | 3 (42.9%) | 0.077 |
25-50% | 4 (26.7%) | 3 (42.9%) | 0.387 |
>50% | 10 (66.7%) | 1 (14.3%) | 0.032 |
Pulmonary function test | Â | Â | Â |
VC | 2.67 ± 0.63 | 2.05 ± 0.64 | 0.1672 |
%VC | 87.37 ± 17.0 | 64.6 ± 23.7 | 0.0947 |
FEV1 | 2.09 ± 0.51 | 1.67 ± 0.32 | 0.1813 |
FEV1/FVC,% | 74.6 ± 7.44 | 80.5 ± 11.2 | 0.3142 |
DLCO | 6.93 ± 3.85 | 5.77 ± 4.56 | 0.733 |
%DLCO | 39.5 ± 16.7 | 31.2 ± 21.5 | 0.5721 |
DLCO/VA | 2.05 ± 0.8 | 2.48 ± 1.49 | 0.6024 |
%DLCO/VA | 46.0 ± 17.4 | 56.3 ± 34.9 | 0.5778 |
EsPAP | 51.5 ± 22.5 | 46.67 ± 9.07 | 0.7379 |
Distribution of TWCLs | Â | Â | Â |
Upper lobe | 12 (80%) | - | - |
Lower lobe | 11 (73.3%) | - | - |
Primary lesion of lung cancer | Â | Â | Â |
Emphysema | 2 (14.3%) | 0 | 0.455 |
Fibrosis | 5 (35.7%) | 3 (60%) | 0.51 |
TWCLs | 4 (26.7%) | - | - |
Others | 3 (20%) | 2 (40%) | 0.523 |
Diffuse alveolar damage | 3 (20%) | 3 (42.9%) | 0.267 |